Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
暂无分享,去创建一个
[1] A. Uygun,et al. Serum leptin levels in patients with nonalcoholic steatohepatitis , 2000, American Journal of Gastroenterology.
[2] D. Sautereau,et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. , 1998, Journal of hepatology.
[3] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[4] L. N. Valenti,et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.
[5] A. Laudanna,et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline‐deficient diet , 2002, Journal of cellular and molecular medicine.
[6] H. Osawa,et al. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes , 1996, Journal of clinical ultrasound : JCU.
[7] Hirokazu Takahashi,et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH , 2007, Journal of Gastroenterology.
[8] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[9] G. Tarantino,et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? , 2009, European journal of gastroenterology & hepatology.
[10] O. Cummings,et al. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? , 2003, American Journal of Gastroenterology.
[11] J. George,et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? , 2002, Hepatology.
[12] G. Targher. Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. , 2006, Journal of hepatology.
[13] E. Roberts,et al. Nonalcoholic steatohepatitis in children , 2003, Current gastroenterology reports.
[14] S. Thung,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in , 2022 .
[15] Y. Iwamoto,et al. Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[16] T. Okanoue,et al. Role of hepatic iron in non‐alcoholic steatohepatitis , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[17] K. Birkeland,et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. , 2006, Journal of hepatology.
[18] D. Amarapurkar,et al. Non‐alcoholic steatohepatitis in type 2 diabetes mellitus , 2004, Journal of gastroenterology and hepatology.
[19] L. Adams,et al. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. , 2007, Clinics in liver disease.
[20] C. Ryan,et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] T. Okanoue,et al. Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.
[22] A. Nakajima,et al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.
[23] F. Schick,et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.
[24] N. Lundbom,et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.
[25] H. Nader,et al. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[26] L Axel,et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. , 1980, Radiology.
[27] E. Tsochatzis,et al. Serum Apoptotic Caspase Activity in Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease , 2010, Journal of clinical gastroenterology.
[28] Sang Won Lee,et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.
[29] A. Diehl. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[30] G. Tarantino,et al. Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non‐alcoholic steatohepatitis , 2007, European journal of clinical investigation.
[31] E. Ulukaya,et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. , 2007, World journal of gastroenterology.
[32] S. Hübscher. Histological assessment of non‐alcoholic fatty liver disease , 2006, Histopathology.
[33] Enzo Bonora,et al. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.
[34] Shi-yao Chen,et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.
[35] J. Crespo,et al. Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .
[36] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.
[37] Dominique Thabut,et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[38] Masahiro Ito,et al. Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[39] M. Kaplan,et al. Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.
[40] M. Gültepe,et al. Diagnostic Value of Serum Prolidase Enzyme Activity to Predict the Liver Histological Lesions in Non-alcoholic Fatty Liver Disease: A Surrogate Marker to Distinguish Steatohepatitis from Simple Steatosis , 2009, Digestive Diseases and Sciences.
[41] G. Gores,et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.
[42] R. Torella,et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[43] Steven P. Larson,et al. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[44] F. Kinjo,et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. , 2005, World journal of gastroenterology.
[45] A. Sanyal,et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[46] F. Moriyasu,et al. Decrease in accumulation of ultrasound contrast microbubbles in non‐alcoholic steatohepatitis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[47] G. Marchesini,et al. Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.
[48] G. Gores,et al. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[49] R. Fisher,et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.
[50] N. Chalasani,et al. Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis , 2004, American Journal of Gastroenterology.
[51] A. Burt,et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease , 2022 .
[52] N. Sattar,et al. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data , 2010, Hepatology.
[53] C. Tiribelli,et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.
[54] J. Goldblum,et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[55] J. Capeau,et al. Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[56] C. Mottin,et al. The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients , 2004, Obesity surgery.
[57] P. Angulo,et al. Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.
[58] V. de Lédinghen,et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[59] Scott Harmsen,et al. Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study , 2010, The American Journal of Gastroenterology.
[60] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[61] A. Feldstein,et al. Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.
[62] S. Harrison,et al. Nonalcoholic Fatty Liver Disease Presenting With an Isolated Elevated Alkaline Phosphatase , 2006, Journal of clinical gastroenterology.
[63] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[64] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[65] P. Newsome,et al. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis , 2010, Alimentary pharmacology & therapeutics.
[66] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[67] A. McCullough,et al. Pathogenesis of non-alcoholic steatohepatitis: human data. , 2007, Clinics in liver disease.
[68] Ayako Suzuki,et al. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[69] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[70] E. Çakır,et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non‐alcoholic fatty liver disease , 2005, Journal of gastroenterology and hepatology.
[71] Henry Völzke,et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma‐glutamyl transpeptidase levels , 2009, Hepatology.
[72] P. Schauer,et al. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[73] L Dalla Palma,et al. Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.
[74] A. J. Bourne,et al. Non‐alcoholic steatohepatitis in children and adolescents , 2000, The Medical journal of Australia.
[75] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[76] Carla Giordano,et al. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1 , 2010, Hepatology.
[77] J. Machan,et al. Nonalcoholic Fatty Liver Disease in Severely Obese Subjects , 2007, The American Journal of Gastroenterology.
[78] E. Fassio,et al. Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. , 2011, Journal of hepatology.
[79] S. Curley,et al. Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.
[80] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[81] S. Pol,et al. FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.
[82] A. Feldstein,et al. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future , 2007, Hepatology.
[83] C. Kittas,et al. Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery , 2009, Obesity surgery.
[84] G. Gores,et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .
[85] G. Gores,et al. Apoptosis in alcoholic and nonalcoholic steatohepatitis. , 2005, Frontiers in bioscience : a journal and virtual library.
[86] J. Marrero,et al. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.
[87] A. Feldstein,et al. Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis , 2008, The American Journal of Gastroenterology.
[88] Z. Younossi,et al. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. , 2005, Clinics in liver disease.
[89] T. Roskams,et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. , 2003, The American journal of pathology.
[90] D. Lobo,et al. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. , 2004, Journal of hepatology.
[91] E. Bonora,et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.
[92] A. Loaeza-del-Castillo,et al. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. , 2008, Annals of hepatology.
[93] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[94] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.
[95] G. Can,et al. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. , 2008, Hepato-gastroenterology.
[96] G. Gores,et al. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.
[97] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[98] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[99] J. Dixon,et al. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.
[100] J. Kench,et al. Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.
[101] Chris Day,et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.
[102] C. Langlotz,et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. , 1998, AJR. American journal of roentgenology.
[103] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[104] B. Neuschwander‐Tetri,et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease , 2010, Hepatology.
[105] P. Thuluvath,et al. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.
[106] I. Guha,et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.
[107] S. Assimakopoulos,et al. Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. , 2008, Acta gastro-enterologica Belgica.
[108] P. Arner,et al. Altered Tumor Necrosis Factor-α (TNF-α) Processing in Adipocytes and Increased Expression of Transmembrane TNF-α in Obesity , 2002 .
[109] D. Schuppan,et al. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease , 2009, Journal of gastroenterology and hepatology.
[110] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[111] F. Oberti,et al. A novel panel of blood markers to assess the degree of liver fibrosis , 2005, Hepatology.
[112] L. Katsnelson,et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.
[113] B. Neuschwander‐Tetri,et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , 2008, Gut.
[114] A. M. Diehl,et al. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? , 1989, Annals of internal medicine.
[115] A. Diehl. Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. , 2001, Alcoholism, clinical and experimental research.
[116] C. Sirlin,et al. Noninvasive assessment of hepatic steatosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[117] Julien Vergniol,et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.
[118] E. Bugianesi. Review article: steatosis, the metabolic syndrome and cancer , 2005, Alimentary pharmacology & therapeutics.
[119] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[120] F. Moriyasu,et al. Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.
[121] Z. Goodman,et al. Diabetic hepatosclerosis: diabetic microangiopathy of the liver. , 2006, Archives of pathology & laboratory medicine.
[122] H. Aburatani,et al. Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH) , 2008, BMC gastroenterology.
[123] F. Poordad,et al. Review article: diagnosis and treatment of non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.
[124] J. Everhart,et al. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. , 2009, Gastroenterology.
[125] S. Mohanty,et al. Nonalcoholic Fatty Liver Disease: A Review and Update , 2010, Digestive Diseases and Sciences.
[126] Mark Fishbein,et al. Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound , 2005, Journal of clinical gastroenterology.
[127] M. Tsutsumi,et al. Usefulness of a Combined Evaluation of the Serum Adiponectin Level, HOMA-IR, and Serum Type IV Collagen 7S Level to Predict the Early Stage of Nonalcoholic Steatohepatitis , 2007, The American Journal of Gastroenterology.
[128] L. Adams,et al. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment , 2011, Nature Reviews Endocrinology.
[129] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[130] A. Tamori,et al. Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis , 2009, Journal of Gastroenterology.
[131] V. Paradis,et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.
[132] Lisa M Yerian,et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.
[133] J. Hoofnagle,et al. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. , 1988, Gastroenterology.
[134] G. Targher,et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.
[135] K. Batts,et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.
[136] Y. Yılmaz. Systematic review: caspase‐cleaved fragments of cytokeratin 18 – the promises and challenges of a biomarker for chronic liver disease , 2009, Alimentary pharmacology & therapeutics.
[137] F. Laine,et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. , 2009, Journal of hepatology.
[138] T. Saibara,et al. 7. 非アルコール性脂肪肝炎 (NASH) の診断と治療 , 2006 .
[139] A. Feldstein,et al. Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.
[140] G. Gores,et al. The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity , 2008, Hepatology.
[141] Hirokazu Takahashi,et al. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage , 2007, Journal of Gastroenterology.
[142] S. Tesfaye,et al. Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[143] Yu Wang,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.
[144] P. Giral,et al. Blood oxidative stress markers are unreliable markers of hepatic steatosis , 2006, Alimentary pharmacology & therapeutics.
[145] H. Blaszyk,et al. Histologic Variation of Grade and Stage of Non-alcoholic Fatty Liver Disease in Liver Biopsies , 2005, Obesity surgery.
[146] A. Moser,et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.
[147] A. Dhawan,et al. Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers , 2007, Hepatology.
[148] R. Hanson,et al. The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.
[149] J. Yodoi,et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. , 2003, Journal of hepatology.
[150] Robert A Hegele,et al. Retinoid X receptor heterodimers in the metabolic syndrome. , 2005, The New England journal of medicine.
[151] J. Kench,et al. High sensitivity C‐reactive protein values do not reliably predict the severity of histological changes in NAFLD , 2004, Hepatology.
[152] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[153] Claude B Sirlin,et al. Imaging features of perivascular fatty infiltration of the liver: initial observations. , 2005, Radiology.
[154] Z. Younossi,et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[155] G. Musso,et al. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity , 2011, Annals of medicine.
[156] J. Rodés,et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis , 1996, Hepatology.
[157] T. Aoyama,et al. Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels , 2010, Journal of clinical gastroenterology.
[158] G. Bedogni,et al. A simple index of lipid overaccumulation is a good marker of liver steatosis , 2010, BMC gastroenterology.
[159] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[160] A. Sanyal,et al. AGA technical review on nonalcoholic fatty liver disease. , 2002, Gastroenterology.